HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

MA-2029

an orally-active motilin receptor antagonist with a modified tripeptide backbone; inhibits motilin-induced intestinal contractions and visceral pain in rabbits; structure in first source
Also Known As:
(S)-N-(S)-((2-(3-tert-butyl-4-hydroxy-phenyl)-1-ethylcarbamoyl-ethyl)-3-methyl-2-methyl-((S)-2-methylamino-3-phenyl-propionyl)amino)butyramide hydrochloride
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Peeters, Theo L: 2 articles (08/2009 - 03/2008)
2. Cynshi, Osamu: 2 articles (08/2009 - 03/2008)
3. Onoma, Mitsu: 2 articles (08/2009 - 03/2008)
4. Sudo, Hirokazu: 2 articles (08/2009 - 03/2008)
5. Yoshida, Shoshin: 2 articles (08/2009 - 03/2008)
6. Muramatsu, Hiroyasu: 2 articles (08/2009 - 03/2008)
7. Kamei, Kenshi: 2 articles (08/2009 - 03/2008)
8. Kuromaru, Osamu: 2 articles (08/2009 - 03/2008)
9. Takanashi, Hisanori: 2 articles (08/2009 - 03/2008)
10. Yogo, Kenji: 2 articles (08/2009 - 03/2008)

Related Diseases

1. Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
2. Hypotension (Low Blood Pressure)
3. Pain (Aches)
4. Diarrhea

Related Drugs and Biologics

1. motilin receptor
2. Motilin

Related Therapies and Procedures

1. Intravenous Infusions
2. Oral Administration